Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accuracy, Acquiom, Addressing, affirmative, aforesaid, Aghion, Alongside, alter, ALX, anal, Anavex, array, Assumption, Atossa, attachment, aTyr, Baltimore, bankruptcy, bear, Ben, Benjamin, bifurcating, BMI, borne, cancer, capped, Chairperson, Chapter, Chimerix, clawback, COBRA, collateral, contemplated, curve, cybersecurity, de, debtor, default, degenerative, DIP, doubt, downgrade, drafted, drawn, earliest, embedded, Exectuvie, exit, fifteen, Florida, footnote, foreclose, forfeiture, Fulcrum, Genomma, Henry, host, IGG, Immunoglobulin, intelligence, Internacional, irreparable, irrevocable, Island, Jaisim, Ji, JV, lengthy, lent, loan, Lyra, maker, meant, MediciNova, Memorial, Michigan, Minerva, mitigate, Moody, multiplied, nerve, Neuroscience, neurosurgeon, Oncology, outlet, owed, Palestinian, par, peripheral, PeriTech, podcast, popular, preceding, prepayment, proceed, Promissory, prompt, promptly, prospective, Rani, recurring, Relmada, repaid, representation, resale, Rhode, Sackler, scenario, Scilex, Scintilla, segment, Shah, Shapiro, SOFR, Sorrento, spike, spine, stable, subscription, Subtopic, supplementary, surgery, tailored, Technowl, terrorist, thereon, threat, timeframe, transparency, trauma, uncured, unpaid, voided, Voluntary, West, Wire, Zevra
Removed:
abovementioned, accompanied, affiliate, agreeable, alleging, attorney, attribution, authoritative, Aviad, cancelation, cancellation, cancelled, cast, CEO, clarify, clarity, closed, Columbia, computation, concurrent, constrained, continuing, created, CSO, dissent, duration, elapsed, enrolled, epidemic, exclude, excluding, finance, Friedman, fulfilled, geography, globally, heavily, heightened, inapplicable, indexing, Itamar, Kevin, LIBOR, mentioned, modification, outbreak, postpone, putative, Rakin, Raz, regrant, reissued, replacement, sake, Schurr, seventeen, shareholder, specialty, spread, staffing, substitution, suggestion, superseded, Underwriter, vendor, versa, vice
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Amendment, Dated April 27, 2023, to Consulting Agreement by and Between Oramed Pharmaceuticals Inc. and Shnida LTD., Entered into As of November 1, 2022, for the Services of Nadav Kidron
- 10.3 Amendment, Dated January 8, 2024, to Consulting Agreement by and Between Oramed Pharmaceuticals Inc. and Shnida LTD., Entered into As of November 1, 2022, for the Services of Nadav Kidron
- 10.5 Amendment, Dated April 27, 2023, to Employment Agreement by and Between Oramed LTD. and Nadav Kidron, Entered into As of November 1, 2022
- 10.6 Amendment, Dated January 8, 2024, to Employment Agreement by and Between Oramed LTD. and Nadav Kidron, Entered into As of November 1, 2022
- 10.15 Amendment, Dated April 27, 2023, to Consulting Agreements by and Between Oramed LTD. and Knry, LTD., Entered into As of July 1, 2008, for the Services of Miriam Kidron
- 10.16 Amendment, Dated January 8, 2024, to Consulting Agreements by and Between Oramed LTD. and Knry, LTD., Entered into As of July 1, 2008, for the Services of Miriam Kidron
- 10.20 Third Amendment, Dated April 27, 2023, to Employment Agreement, by and Between Oramed LTD. and David Silberman
- 10.21 Fourth Amendment, Dated January 8, 2024, to Employment Agreement, by and Between Oramed LTD. and David Silberman
- 10.22 Representative Form of Indemnification Agreements Between Oramed Pharmaceuticals Inc. and Each of Our Directors and Officers
- 23.1 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- 97.1 Oramed Pharmaceuticals Inc. Clawback Policy, Adopted November 9, 2023
- Download Excel data file
- View Excel data file
ORMP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-252696 and 333-257926 and 333-257128) and Form S-8 (Nos. 333-244380, 333-234303, 333-213835, 333-199120, 333-190222, 333-163919 and 333-266105) of Oramed Pharmaceuticals Inc. of our report dated March 6, 2024 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
March 6, 2024 | Certified Public Accountants (Isr.) |
A member firm of PricewaterhouseCoopers International Limited |